Public-registry site landscape for NCT04219982, a Motion Sickness study sponsored by Repurposed Therapeutics, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04219982 (registry record) |
| Sponsor | Repurposed Therapeutics, Inc. |
| Condition(s) | Motion Sickness |
| Phase | PHASE2 / PHASE3 |
| Listed sites | 1 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT04219982 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →